论文部分内容阅读
Medicis Pharmaceutical Corp．公司3月2日宣布,美国FDA批准其抗银屑病药醋酸氟轻松(fluocinonide, Vanos)用于治疗几种其他常见的皮肤病,如12岁或以上患者的湿疹和常春藤
Medicis Pharmaceutical Corp. The company announced on March 2 that the U.S. FDA approved its anti-psoriasis fluocinonide (Vanos) for the treatment of several other common skin disorders such as eczema and ivy in patients 12 and older